Delivery formulations

Transforming Clinical Development

Content provided by PerkinElmer | 01-May-2021 | White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Flow Cytometry Services

Content provided by Q² Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Controlled Nucleation: more than just a homogenization tool

Content provided by Telstar Life Science Solutions | 30-Sep-2019 | Case Study

A new vacuum induced nucleation method in the freeze-drying process, Telstar Lyonuc, reduces the duration of the primary drying cycle and ensures the homogenization...

From Candidate to Clinic- European Capabilities

Content provided by Catalent | 22-Oct-2018 | White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Customized Fill Release in Gelatine Soft Capsules

Content provided by Gelita AG | 07-May-2018 | Application Note

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Strategies to Select and Deliver the Right Candidate

Content provided by Catalent | 05-Mar-2018 | White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Optimizing vessel geometry for mag drive agitators

Content provided by Steridose, Inc | 14-Sep-2017 | White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

GELITA® Gelatine for State-of-the-Art Delivery Systems

Content provided by Gelita AG | 21-Aug-2017 | White Paper

The latest development of the GELITA Competence Team is GELITA® RXL R2 that takes the reduced cross-linking (RXL) concept provided by GELITA® RXL one step...

First-in-Human Development Strategies

Content provided by Catalent | 01-May-2017 | Insight Guide

Crucial and cost-effective factors to consider when transforming a pre-clinical development compound into a first-in-human, early-phase drug candidate....

Producing the perfect soft gel

Content provided by Leading manufacturer of gelatine and collagen peptides | 17-Jan-2017 | White Paper

This white paper outlines the key considerations to ensure gelatin is enhanced for soft gel formulation, efficient gel production and optimal API delivery...

Nemera: Using intelligent design to deliver safe preservative free multi-dose eye drops

Content provided by Nemera | 12-Dec-2016 | White Paper

Novelia® represents a major innovation in ophthalmic drug delivery by providing a preservative-free alternative for chronic treatments in a patient-friendly...

Patient-Centric Drug-Development Process

Content provided by Catalent | 28-Nov-2016 | Insight Guide

For large and small pharmaceutical companies alike; developing a new drug is fraught with risk. Patient-centric drug development and optimization is both...

Choosing the Right Size Sphere

Content provided by Colorcon Inc. | 21-Nov-2016 | White Paper

Choosing the right size sugar sphere, for a multiparticulate dosage form is imperative.  Size matters; not only to achieve a robust formulation and efficient...

Experience foam for topical drug delivery

Content provided by Gattefossé | 14-Nov-2016 | White Paper

Pharmaceutical foams are becoming more popular probably due to more topical medicines being switched to OTC and the need to innovate and differentiate...

Healthy and suitable for all types of patient, SweetPearl® or LYCASIN® is what you need!

Content provided by Roquette Pharma Solutions | 25-Oct-2016 | Product Brochure

The quality and stability of your formulations is your ultimate challenge.Whether you need the optimal diluent for your solid dosage forms or the ideal...

Challenges and SEPPIC solutions for moisture sensitive formulation

Content provided by SEPPIC | 24-Oct-2016 | White Paper

One of the challenges of the formulators is to develop stable formulations which protect API from moisture. To find solutions and different ways of protecting...

FDA Focus̶ Product Design and Post Approval Changes

Content provided by Colorcon Inc. | 19-Sep-2016 | White Paper

Review a new Colorcon Technical Paper offering a summary of key points presented in the recent US Center for Drug Evaluation and Research (CDER) Guidance...

Impact of Extrusion Process Parameters on Drug Recovery and Dissolution

Content provided by Information not available | 04-Jul-2016 | White Paper

This technical paper studies the impact of extrusion process parameters on the performance of solid dispersions of Ritonavir, a poorly soluble antiretroviral...

New Organic Coating System to Modulate Drug Release

Content provided by Colorcon Inc. | 09-May-2016 | White Paper

A Colorcon Study, Effect of Coating Weight Gain and Pore-Former Level on Drug Release with a Fully Formulated Ethylcellulose Barrier Membrane Coating System,...

Considerations in Purchasing a LIMS

Content provided by Abbott Informatics | 27-Apr-2016 | White Paper

Many scientific enterprises find themselves in need of a Laboratory Information Management System (LIMS) to replace an incumbent system, whether an existing...

Advanced Analytics architecture and the benefits it serves as an integrated solution

Content provided by Abbott Informatics | 18-Apr-2016 | White Paper

A laboratory’s day-to-day operations are recorded through STARLIMS, accumulating data over time.This data includes sample lifecycle information and metadata.A...

Single-Pass TFF and the New Era of Bioprocessing

Content provided by Pall Biotech | 11-Apr-2016 | White Paper

Learn how single-pass tangential flow filtration (SPTFF) technology is revolutionizing current and future bioprocessing platforms with its implementations...

White paper: ensure quality in novel dosage forms

Content provided by Stable Micro Systems | 14-Mar-2016 | White Paper

From oral sprays to pastilles and capsules, pharmaceutical products must increasingly cater for a wider range of preferences. Download this free white...

UPLC Analysis of Methoxy & 2-Hydroxypropoxy in Hypromellose

Content provided by SGS Life Science Services | 22-Feb-2016 | White Paper

Because of its use in the pharmaceutical and food industries, the USP has established standards relating to the amount of methoxyl and 2-hydroxypropoxyl...

Passive safety device, assessing the impact on drug dose delivery

Content provided by Nemera | 18-Jan-2016 | White Paper

Drug dose delivery is key for pharmaceutical companies as it impacts treatment efficiency and drug overfilling. This paper investigates the impact of three...

Leveraging ADVASEPT® Technology

Content provided by Catalent | 14-Dec-2015 | Case Study

Catalent’s ADVASEPT® Technology is an advanced aseptic manufacturing process that leverages blow-fill-seal (BFS) technology to create a glass free container...

Selecting the best platform for optimization of ODT disintegration time

Content provided by Roquette | 03-Dec-2015 | Case Study

Orally Disintegrating Tablets (ODTs) are of growing interest as delivery systems for the administration of active ingredients in Pharmaceutics and Nutraceutics.One...

Efficient skin delivery: no compromise with Transcutol®

Content provided by Gattefossé | 30-Nov-2015 | White Paper

This white paper describes Transcutol®, the highest purified pharmaceutical grade of Diethylene Glyceryl monoEthylEther (DEGEE).Scientific publications...

Maltitol in taste masking of acetaminophen chewable tablets: A synergy of combination

Content provided by Roquette Pharma Solutions | 09-Nov-2015 | White Paper

Masking the bitter taste of acetaminophen in chewable tablets is always a challenge, especially in pediatric tablets where formulation possibilities are...

Safelia™ autoinjector designed to be patient and syringe friendly

Content provided by Nemera | 26-Oct-2015 | White Paper

Nemera’s new generation of 2-steps autoinjectors for fluid and viscous injections.How to avoid by design glass breakage when injecting  1ml or 2.25ml highly...

Impact of the lubricant mixing time on the compactibility and disintegration time for mannitol compacts

Content provided by Roquette Pharma Solutions | 21-Sep-2015 | Research Study

The objective of this study was to evaluate the impact of Magnesium Stearate (MgSt) mixing conditions on the compaction behavior and disintegration time...

Lipid formulations: from effective prediction to successful development

Content provided by Gattefossé | 31-Aug-2015 | White Paper

This white paper describes the important milestones achieved in lipid based formulation (LBF) development for oral drug delivery.Collaborative research...

Article on Viral Clearance for Biopharmaceuticals

Content provided by Catalent | 24-Aug-2015 | White Paper

Viral clearance studies are mandated prior to entering clinical trials and for commercial launch of biopharmaceuticals.  These studies are a key component...

Evonik Solutions for Alcohol Induced Dose Dumping

Evonik Health Care | Recorded the 10-Sep-2015 | Webinar

Details the physiology related to alcohol consumption and its subsequent impact on drug release. Effective formulation strategies for meeting the physiological...

Glass to plastic: a gas barrier PFS for biologics

Content provided by Nemera | 13-Jul-2015 | Research Study

Gas permeability remains a main challenge of plastic prefilled syringes, preventing an increased uptake in some applications. Nemera has developed an innovative...

GELITA® RXL technology prevents cross-linking

Content provided by Gelita AG | 06-Apr-2015 | Data Sheet

The GELITA Pharmaceutical Competence Team has developed a new technology: GELITA® RXL (Reduced Cross-Linking gelatine) that adds extra value to gelatine...

Customized Biosimilarity Analytical Testing from Catalent

Content provided by Catalent | 26-Jan-2015 | White Paper

Assessment of biosimilar molecules requires an orthogonal analytical approach.  Any one particular analytical technique is not able to fully define the...

OptiPact™ Technology Introduced by Catalent

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health...

Meaningful Metrics – A CMO Perspective

Content provided by Patheon Inc | 19-Jan-2015 | White Paper

Learn about the roles of sponsors and their contract manufacturing organization (CMO) partners regarding metrics, what metrics to measure, how to manage...

Solid Lipid Excipients: Born to be Extruded !

Content provided by Gattefossé | 17-Nov-2014 | White Paper

Functional excipients are critical to the successful application of HME to resolve formulation challenges. Whilst polymers show potential in both controlled...

Maximize Excipient Purity to Optimize Efficacy

Content provided by Croda Inc | 29-Sep-2014 | Information Request

The purity of your excipient can have a profound impact on your formulation’s performance, affecting both the stability of the drug and the final formulation....

12 Weeks to Phase I Clinical Trial Materials

Content provided by Patheon Inc | 01-Sep-2014 | Clinical Study

Learn how in twelve weeks from receiving your API, you can have bulk clinical trial materials for First in Man trials. The Quick to Clinic™ program includes...

Smart strategies for sustained release matrix tablets: Compritol® 888 ATO

Content provided by Gattefossé | 19-May-2014 | White Paper

This white paper gives an overview of how Compritol® 888 ATO provides clinically relevant sustained drug release profiles along with biopharmaceutical,...

Film Coating for Taste-masking of an HIV Drug for Pediatrics

Content provided by Colorcon Inc. | 25-Mar-2014 | Case Study

MSD evaluated several taste-masking options to coat raltegravir granules, for pediatric dosing.  They chose a coating comprised of Surelease®, aqueous...

Method Development and Validation for Nutraceuticals

Content provided by RSSL | 12-Dec-2013 | White Paper

Nutraceutical is a term formed from the amalgamation of the words “pharmaceutical” and “nutrition” by Dr Stephen Felice in 1989. Others have since tried...

Mitigating Medication Errors with Tablet Design

Content provided by Colorcon Inc. | 09-Dec-2013 | White Paper

Medical prescription drug errors by doctors, pharmacists and patients account for 1.5 million incidences of sickness, injuries or deaths in the U.S. each...

NEOBEE® MCTs Enhance Pharmaceutical Bioavailability

Content provided by Stepan Lipid Nutrition | 04-Nov-2013 | White Paper

An efficient solvent for many lipophylic drugs and vitamins, NEOBEE® MCTs emulsify in aqueous environments and help uptake in intestinal cells. They are...

Improving API Stability with Increased Excipient Purity

Content provided by Croda Inc | 14-Oct-2013 | Data Sheet

Sensitive or unstable APIs can pose formulating challenges when it comes to ensuring their consistent and safe delivery.  Data indicate that the purity...

CONFIDENCE IN BIOLOGICS FORMULATION DESIGN

Content provided by SGS Life Science Services | 07-Oct-2013 | White Paper

To ensure a long product shelf-life for biopharmaceutical drug products, a stable storage environment is critical. Determination of the optimal environment...

Hyaluronic acid is now measured on the Hyasis® scale

Content provided by Information not available | 16-Sep-2013 | White Paper

Hyasis is derived from a state-of-the-art Bacillus-based production process utilizing only water for purification with no animal-derived raw materials...